Departed
Daniel Burgess
Director
ABUS ·
Arbutus Biopharma Corp
Daniel Burgess
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4001–4050 of 75357
Daniel Burgess
James Meyers
Richard C. Henriques
Frank Torti, M.D., chairperson of the Board
Melissa V. Rewolinski, Ph.D.
Keith Manchester, M.D.
Michael J. McElhaugh
Sabrina Simmons succeeded Brian LaRose as the Company’s Chief Financial Officer (the “CFO Succession”), effective as of February 17, 2025
Christopher Begley, the Company’s Chairman of the Board, is not eligible for nomination by the Board for election as a director at the 2025 Annual Meeting and will retire from the Board when his current term expires at such meeting.
John R. Miller III notified the Board of his intent to retire from the Board, effective upon the completion of the 2025 Annual Meeting.
On February 25, 2025, Gerard Cunningham notified the Board of Directors (the “Board”) and the Corporate Secretary of Stem, Inc. (the “Company”) of his resignation from the Board effective February 28, 2025 for personal reasons.
who notified the Company on the Effective Date that he is leaving the Company to pursue another professional opportunity effective as of the Effective Date.
Mr. Sullivan’s departure was not as a result of any dispute with the Company.
In connection with the appointment of Mr. Kazmaier, Sayan Chakraborty will retire from his role at Workday as President, Product and Technology, effective as of the Effective Date.
As previously announced by the Company on its Current Report on Form 8-K filed on September 25, 2024, John C. Malone, a member of the Board, will not stand for reelection and will cease being a member of the Board when his current term expires at the 2025 annual meeting.
On February 19, 2025, Andrea L. Wong notified QVC Group, Inc. (the “ Company ”) that she does not intend to stand for reelection as a member of the Board of Directors (the “ Board ”) of the Company.
Directors, Mr. William McDevitt and Mr. Sanjiv Sanghvi notified the Company on February 19, 2025, that each will serve out their current term for Director until the Company's 2025 Annual Meeting of Shareholders, but will not stand for re-election at such meeting.
Directors, Mr. William McDevitt and Mr. Sanjiv Sanghvi notified the Company on February 19, 2025, that each will serve out their current term for Director until the Company's 2025 Annual Meeting of Shareholders, but will not stand for re-election at such meeting.
Mr. Wayne Edmunds informed MSCI Inc. (“MSCI” or the “Company”) of his decision to retire from the Board of Directors (the “Board”) of the Company and not stand for re-election at the Company’s 2025 Annual Meeting of Shareholders.
On February 25, 2025, the company’s Board of Directors resolved to acknowledge that Mr. Marino Papazoglou has resigned from the board as a director of the company, effective immediately.
on February 20, 2025, the Company and Mr. Mattacchione agreed to extend the effective date of Mr. Mattacchione’s resignation to no later than March 7, 2025, in order to provide the Company the necessary time to complete an efficient transition of the Chief Executive Officer position.
On February 18, 2025, the Board of Pineapple Financial Inc. (the " Company ") received by email a resignation letter from Nima Besharat, a director of the Company, pursuant to which Mr. Besharat resigned as director of the Company, effective immediately.
each of Mark Goldberg, M.D., Scott Jackson, Rachel King, and Scott Koenig, M.D., Ph.D. tendered their resignations from the Company’s Board of Directors, effective as of February 21, 2025.
Mr. Semerjian also resigned from the Board of Directors effective as of February 21, 2025.
each of Mark Goldberg, M.D., Scott Jackson, Rachel King, and Scott Koenig, M.D., Ph.D. tendered their resignations from the Company’s Board of Directors, effective as of February 21, 2025.
each of Mark Goldberg, M.D., Scott Jackson, Rachel King, and Scott Koenig, M.D., Ph.D. tendered their resignations from the Company’s Board of Directors, effective as of February 21, 2025.
each of Mr. Harout Semerjian, the Chief Executive Officer of the Company and Mr. Brian Hahn, the Company’s Chief Financial Officer, ceased his respective employment with the Company as of February 21, 2025
each of Mr. Harout Semerjian, the Chief Executive Officer of the Company and Mr. Brian Hahn, the Company’s Chief Financial Officer, ceased his respective employment with the Company as of February 21, 2025
each of Mark Goldberg, M.D., Scott Jackson, Rachel King, and Scott Koenig, M.D., Ph.D. tendered their resignations from the Company’s Board of Directors, effective as of February 21, 2025.
On February 21, 2025, Amy Butte, a member of the Board of Directors (the “Board”) of the Company, notified the Company of her intention not to stand for reelection at the Company’s 2025 Annual Meeting of Stockholders (the “Annual Meeting”).
On February 25, 2025, Lucid Group, Inc. (“ Lucid ” or the “ Company ”) announced that Peter Rawlinson, the Company’s Chief Executive Officer (“ CEO ”) and Chief Technology Officer, resigned from his positions and the Company’s board of directors (the “ Board ”) on February 21, 2025 (the “ Effective Date ”).
On January 30, 2025, Ryan Spick, the Principal Executive Officer and Chief Financial Officer of Fortune Rise Acquisition Corporation, a Delaware corporation (the “ Company ”), notified the Company of his plans to resign from the Company to pursue other opportunities, effective immediately.
the resignation of Patrick McCarter, which was received February 19, 2025 and will become effective at the end of the day on February 28, 2025.
On February 24, 2025, Jonathan Fitzpatrick, President and Chief Executive Officer (“CEO”) of the Company, informed the Company of his intent to step down as President and CEO effective May 9, 2025 and terminate his employment with the Company (the “Transition Date”).
On February 19, 2025, Sean Murphy notified TriSalus Life Sciences, Inc. (the “Company”) of his intent to step down as an officer and employee of the Company effective February 28, 2025.
On February 25, 2025, the Company announced the resignation of Greg Henry as the Company’s Chief Financial Officer.
director C. Todd Asbury will not stand for reelection and will step down from the board of directors effective with the Annual Meeting of Shareholders scheduled for May 20, 2025.
On February 21, 2025, Franklin Electric Co., Inc. (the “Company”) and Jeffery Taylor mutually agreed that Mr. Taylor will separate from the Company and resign as Chief Financial Officer of the Company as of March 28, 2025.
On February 20, 2025, Semtech Corporation, a Delaware corporation (“Semtech” or the “Company”), entered into a Separation and General Release Agreement (the “Separation Agreement”) with Mark P. Russell, the Company’s Senior Vice President, Global Sales and Marketing. The Separation Agreement provides that Mr. Russell’s last day of employment with the Company will be March 6, 2025 (the “Separation Date”).
On February 19, 2025, Mary C. Hemmingsen, a member of the Board and a member of the Audit/Finance Committee, advised the Company that owing to her significant work and board load as partner at Moneta Securities and her audit chair role for four companies, she will not stand for re-election to the Board at the Company's 2025 Annual Meeting of Shareholders.
On February 19, 2025, Lynda L. Ziegler, a member of the Board of Directors (the Board) of Itron, Inc. (the Company), the chair of the Nominating and Corporate Governance Committee, and a member of the Compensation Committee, notified the Company that she will retire when her term ends and, therefore, not stand for re-election to the Board at the Company’s 2025 Annual Meeting of Shareholders.
On February 20, 2025, Darin Harris notified the Company’s Board of Directors of his intention to resign from his positions as Chief Executive Officer and Director of the Company, effective immediately, to pursue other opportunities.
On February 19, 2025, Robert A. Rango, a member of the Board of Directors (the "Board") of Microchip Technology Incorporated (the "Company"), retired from the Board effective as of February 19, 2025.
On February 19, 2025, Dan O. Dinges informed the Board of Directors (the “Board”) of Coterra Energy Inc. (the “Company”) of his decision to retire from the Board at the end of his current term and not stand for re-election as a director at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
Also on February 19, 2025, Robert S. Boswell informed the Board of his decision to retire from the Board at the end of his current term and not stand for re-election as a director at the 2025 Annual Meeting.
As of February 22, 2025, Dian C. Taylor is no longer serving as the Company’s Chief Executive Officer and President.
Paul J. Diaz, the Company’s President and Chief Executive Officer, announced on February 24, 2025 that he will step down from those positions, and resign from the Company’s Board of Directors (the “Board”), on April 30, 2025
Mr. Doogue succeeds Vineet Nargolwala, who is stepping down as President and Chief Executive Officer and as a member of the Board.
On February 24, 2025, MasterCraft Boat Holdings, Inc. (the “Company”) announced that current President of the Company’s Pontoon segment, George Steinbarger, departed the Company effective February 24,2025.
Jeffrey S. Kelly Departure On February 24, 2025, the Company terminated
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.